ALZN
Alzamend Neuro, Inc.
+0.00 (+0.27%)1.84USD17.3K成交股數8.9M市值–本益比(近四季)5190.6股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 4 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 27Q1 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.1M | 1.3M | 176K | 1.7M | 450K | 447K | 311K | 207K | 1.9M | 2.0M | 2.4M | 1.6M |
| 銷售管理費用 | 1.9M | 919K | 822K | 959K | 689K | 590K | 1.0M | 756K | 751K | 905K | 1.2M | 1.7M |
| 營業利益 | −3.0M+166% | −2.2M+112% | −998K-27% | −2.7M+181% | −1.1M-57% | −1.0M-64% | −1.4M-61% | −962K-71% | −2.7M | −2.9M | −3.5M | −3.3M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −3.0M+166% | −2.2M+112% | −1.0M-26% | −2.7M+177% | −1.1M-57% | −1.0M-64% | −1.4M-61% | −974K-71% | −2.7M | −2.9M | −3.5M | −3.3M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.68-112% | -0.58-67% | -0.30-92% | -1.28-89% | 5.46-245% | -1.75-60% | -3.61-33% | -11.42-47% | -3.77 | -4.43 | -5.38 | -21.55 |
| 稀釋股數 | 4.5M | 3.8M | 3.4M | 2.1M | 451K | 612K | 392K | 85.3K | 705K | 656K | 656K | 650K |
資產負債表 期末餘額
| 科目 | 27Q1 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 7.6M | 2.7M | 4.4M | 5.6M | 3.9M | 3.4M | 4.1M | 1.2M | 283K | 200K | 1.7M | 5.1M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 8.5M | 4.0M | 5.1M | 6.3M | 4.6M | 4.2M | 5.0M | 1.7M | 783K | 984K | 2.6M | 5.9M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 2.7M | 1.9M | 717K | 983K | 635K | 726K | 1.3M | 2.9M | 4.6M | 3.7M | 2.7M | 2.9M |
| 股東權益 | 5.8M | 2.2M | 4.4M | 5.3M | 4.0M | 3.4M | 3.8M | −1.2M | −4.3M | −2.7M | −113K | 3.0M |
| 負債比 | 32.1% | 46.0% | 14.1% | 15.5% | 13.8% | 17.4% | 25.1% | 172.6% | 583.8% | 372.7% | 104.3% | 48.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 27Q1 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | −1.1M | – | – | −2.4M+124% | – | – | – | −1.1M | – | – | −3.3M | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | – | – | −8.8M | –% | -2.63 | – |
| FY2025 | – | – | −4.5M | –% | -11.32 | – |
| FY2024 | – | – | −9.9M | –% | -132.33 | – |
| FY2023 | – | – | −14.9M | –% | -22.89 | – |
| FY2022 | – | – | −12.4M | –% | -0.14 | – |
| FY2021 | 2K | -87.7% | −5.0M | -295,812.8% | -0.07 | – |
| FY2020 | 14K | – | −4.4M | -31,671.4% | -0.06 | – |